Increased cytokine production (IL-6, IL-1, TNF-α) observed during IBD is known to influence cancer initiation and progression as cytokines can promote growth and prevent apoptosis while also facilitating invasion and metastasis. Here, IL6 is linked to inflammatory bowel disease.